Ensuring the Voice of the Very Severely Affected Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patient Is Heard in Research-A Research Model. — CFSMEATLAS
Ensuring the Voice of the Very Severely Affected Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patient Is Heard in Research-A Research Model.
Baxter, Helen · Healthcare (Basel, Switzerland) · 2022 · DOI
Quick Summary
Most ME/CFS research has only included patients well enough to visit clinics, which means the most severely affected patients—those who are housebound or bedbound—have been left out. This study showed that very severely affected patients can participate in research if researchers make practical adjustments, like allowing phone or text responses instead of requiring in-person visits. By reaching out directly to these patients, researchers were able to gather their important experiences and insights.
Why It Matters
This research is critical because the most severely affected ME/CFS patients have been systematically excluded from studies, meaning their needs and experiences are largely invisible in the medical literature. By demonstrating practical methods to include these patients, the study could fundamentally change how ME/CFS research is conducted and ensure that treatments and interventions are developed with input from the entire patient population. This represents an important step toward equitable research that doesn't inadvertently exclude the most vulnerable patients.
Observed Findings
Very severely affected ME/CFS patients were successfully able to participate in research when provided reasonable adjustments such as telephone and text-based questionnaire completion.
Direct outreach to very severely affected patients was an effective recruitment strategy for a population previously labeled 'hard to reach'.
Patients completing questionnaires by alternative methods (phone/text) provided valuable data comparable to traditional formats.
Inferred Conclusions
Future ME/CFS research should routinely incorporate reasonable adjustments to enable participation of very severely affected patients.
The exclusion of very severely affected patients from research has created a significant gap in understanding ME/CFS experiences and needs.
Inclusive research methodologies can serve as a model for other chronic illness research involving severely affected populations.
Remaining Questions
What specific data or insights from very severely affected patients differs from or complements data gathered from ambulant patients?
Which reasonable adjustments are most effective and feasible for different types of research (qualitative, quantitative, longitudinal)?
How can researchers balance the need for inclusive participation with managing patient burden and avoiding overexertion in very severely affected individuals?
What This Study Does Not Prove
This study does not establish the effectiveness of any particular treatment or intervention for ME/CFS. It is a methods paper that demonstrates feasibility of inclusive recruitment approaches, not a clinical trial. The study does not prove that very severely affected patients' experiences differ from ambulant patients in specific ways, nor does it establish prevalence rates of any particular complication like the need for tube feeding.